ARTICLES BY MATHINI ILANCHERAN
-
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing10/17/2025
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.
-
India's New Drugs, Medical Devices, And Cosmetics Draft Bill 202211/7/2022
To accommodate changing requirements and encourage the adoption of new technology, India’s Ministry of Health and Family Welfare released a draft bill in July 2022 to replace the existing Drugs and Cosmetics Act 1940. What are the major areas of change and how much of an impact will there be?